Provided by Tiger Trade Technology Pte. Ltd.

GraniteShares YieldBoost HIMS ETF

5.38
+0.01080.20%
Post-market: 5.390.0104+0.19%19:34 EDT
Volume:3K
Turnover:18.13K
Market Cap:753.14K
PE:- -
High:5.41
Open:5.41
Low:5.36
Close:5.37
52wk High:25.79
52wk Low:5.27
Shares:140.00K
Float Shares:140.00K
Volume Ratio:0.99
T/O Rate:2.40%
Dividend:8.82
Dividend Rate:163.86%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Is Hims & Hers Health (HIMS) A Bargain After The Fraud Lawsuit Claims?

Simply Wall St.
·
2 hours ago

Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)?

Simply Wall St.
·
Yesterday

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,461 Common Shares Worth $100,964.37

Reuters
·
Yesterday

Hims & Hers Names Kultar Garcha UK and EMEA Chief Medical Officer

Reuters
·
Oct 01

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening Its Investment in Local Clinical Leadership

THOMSON REUTERS
·
Oct 01

Hims & Hers Health, - Appoints Kultar Garcha as Chief Medical Officer UK and Emea; Matt Vickers as Chief Medical Officer Australia

THOMSON REUTERS
·
Oct 01

ETF Daily | FOMG Soars 19%; CBRZ Jumps 18%; BEZ Climbs 10%; JBLG Plunges 21%; Inverse Equity Funds Lead

ETF Tracker
·
Oct 01

Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15

Reuters
·
Sep 24

Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%

TIPRANKS
·
Sep 23

100 Million UUSD Tokens Debut on Robinhood Chain as Tokenized Equity Push Accelerates

Stock News
·
Sep 21

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Reuters
·
Sep 18

Moderately bullish activity in Hims and Hers Health with shares up 0.47%

TIPRANKS
·
Sep 17

Bank of America Securities Sticks to Its Hold Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
Sep 15

Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan

Dow Jones
·
Sep 11

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Reuters
·
Sep 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)

TIPRANKS
·
Sep 02

Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market Presence

Reuters
·
Sep 01

Hims & Hers Enters Australia in First Asia-Pacific Expansion

Reuters
·
Sep 01

Hims & Hers Offers GLP-1 Weight-Loss Drugs, Men's Health Treatments in Australia

Reuters
·
Sep 01

How GLP-1 Sales Could Play Out for Hims & Hers

Dow Jones
·
Aug 26